Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,393
Award facts
- Contract value 100% obligated
- $82,392.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $82,392.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 15, 2026, with an ultimate completion date of January 16, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499,999,999 contract awarded in November 2025 that positions the company as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy.
Under this delivery order, DMS Pharmaceutical Group will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The company's product portfolio encompasses an extensive range of offerings including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals such as oncology treatments, immunosuppressants, emergency medications, and routine therapeutic agents. The PPV-G GEN V contract structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for recurring medical supply needs across military healthcare facilities, with the contractor's established performance on numerous prior awards demonstrating its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMRA?
SPE2DU26FEMRA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DU26FEMRA worth?
The government has obligated $82,393 on SPE2DU26FEMRA.
Is contract SPE2DU26FEMRA an order under another contract?
Yes. SPE2DU26FEMRA is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRA competed?
The extent of competition for SPE2DU26FEMRA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award